Catalyst Wire Dossier Catalyst Wire Dossier

Evobrutinib

evobrutinib · Merck KGaA
Drug timelines are a Plus or Pro feature.

9 regulatory and trial events tracked for Evobrutinib, covering 2020-09-28 to 2026-01-15. Get the full timeline:

Most recent: Clinical Trial Update: DDI Study of Evobrutinib and Carbamazepine [Phase 1]

See pricing